Candel Therapeutics
Ted Jenkins is a seasoned professional in investor relations and business development, currently serving as Vice President of Investor Relations and Business Development at Candel Therapeutics. Previously, Ted held the position of Vice President and Head of Investor Relations at Spero Therapeutics, and Senior Director of Investor Relations and Communications at Corbus Pharmaceuticals. Additionally, Ted is a member of the Board of Directors at Archer Pharmaceuticals, Inc. and provides strategic pharmaceutical consulting through CrossBio Development LLC.
This person is not in any teams
This person is not in any offices
Candel Therapeutics
1 followers
Located in Needham, MA, Candel is committed to saving, extending, and improving the lives of cancer patients through oncolytic viral immunotherapies.